UPTquik® Lp-PLA2 Kit

Company: hotgen

Website: www.hotgen.com.cn

Product: UPTquik® Lp-PLA2 Kit

​

UPTquik® Lp-PLA2 Kit

UPTquik® Lp-PLA2 is an accurate, rapid, fully quantitative test used on UPTquik® Reader for the determination of Lipoprotein Associated Phospholipase A2 (Lp-PLA2) in human serum and plasma as a risk marker for cardiovascular disease.

Lp-PLA2: the independent risk marker for cardiovascular disease

Lipoprotein-associated phospholipase A2 (Lp-PLA2) is also known as platelet-activating factor acetylhydrolase (PAF-AH).  Lp-PLA2 is an enzyme that appears to play a role in the inflammation of blood vessels and is thought to help promote atherosclerosis.

Some recent studies have shown that Lp-PLA2 is an independent risk marker for cardiovascular disease (CVD), including coronary heart disease (CHD), and ischemic stroke. The Lp-PLA2 test is thus used to help evaluate a person's risk of developing coronary heart disease (CHD) or to help determine the risk of having an ischemic stroke.

The test would typically be used to evaluate an individual who is at a moderate to elevated risk for CHD or stroke, someone with one or more other risk factors. For instance, it may be ordered when someone has normal or minimally elevated lipid levels, borderline high blood pressure (hypertension), or metabolic syndrome.

An Lp-PLA2 test may sometimes be used along with an hs-CRP test to evaluate a person's level of underlying inflammation associated with CVD risk. However, unlike hs-CRP, the Lp-PLA2 test is not affected by conditions other than CVD that can cause general inflammation, so it may be used when someone has an inflammatory condition, such as arthritis.

UPTquik® Lp-PLA2Kit Test Principle

Up-converting Phosphor Technology

UPTquik® Lp-PLA2KitFeatures

Fully quantitative measurement

Rapid, accurate, lab quality results within minutes

Ready-to-use reagents

Serum, plasma are applicable as sample

Long shelf life

Easy storage at room temperature

Single dose format: run only the test you need